What is the rating for LION stock?

Lionsgate Studios Corp. (LION) has a "Hold" rating based on our 6-factor quantitative model. It has a composite score of 57.1 and ranks #1010 out of 7,333 stocks in our coverage universe with a 3-star rating.

Is LION a good stock to buy?

Based on our quantitative analysis, LION receives a "Hold" rating with 3 out of 5 stars. Key factors include: Quality score of 55.1, Value score of 78.1, and Momentum score of 79.8. The timing score is 54, indicating "Neutral" entry conditions. This is not investment advice - please conduct your own research.

What sector is LION in?

Lionsgate Studios Corp. (LION) operates in the Services sector, specifically in the Entertainment industry. It has a market capitalization of $2.19 billion.

What is LION's P/E ratio?

LION has a P/E (Price-to-Earnings) ratio of 65.30x. This helps investors assess whether the stock is trading at a premium or discount relative to its earnings.

Does LION pay a dividend?

LION does not currently pay a dividend.

What is LION's market cap?

Lionsgate Studios Corp. (LION) has a market capitalization of $2.19 billion, making it a mid-cap stock.

What are the risks of investing in LION?

Key risk factors for LION include: notable short interest, and general market risk. As with all investments, there is risk of loss.

How does LION compare to peers?

Within the Services sector, LION ranks #1010 overall with a quality score of 55.1/100 and value score of 78.1/100.

What is LION's revenue growth?

LION has revenue growth of -12.1% year-over-year.

What is LION's composite score?

Lionsgate Studios Corp. (LION) has a composite score of 57.1/100, which places it at rank #1010 out of 7,333 stocks. This score is derived from our proprietary 6-factor quantitative model that evaluates quality, value, momentum, investment efficiency, stability, and short interest.

How does LION compare to the S&P 500?

LION ranks in the top 86% of all stocks in our coverage universe with a composite score of 57.1.

What are the bull and bear cases for LION?

Bull case: LION scores highest in momentum at 79.8/100, indicating strong performance in this area. Bear case: The weakest factor is short interest at 26.8/100, which may present a risk. Our overall assessment is Hold with 3 out of 5 stars.

Is LION overvalued or undervalued?

LION appears undervalued based on our value factor score of 78.1/100. With a P/E of 65.3x, the stock trades at an attractive valuation relative to its fundamentals.

What is LION's momentum score?

LION has a momentum score of 79.8/100, placing it in the strong category. This indicates strong recent price performance and institutional accumulation.

When is LION's next earnings date?

For the latest earnings date and analysis for LION, visit our earnings calendar or check the LION stock page for real-time updates. Our AI-generated earnings reports provide in-depth analysis after each quarterly report.

Is LION a good stock to buy right now?

Based on our 6-factor quantitative model, Lionsgate Studios Corp. (LION) receives a "Hold" rating with a composite score of 57.1/100. It is ranked #1010 out of 7,333 stocks. Key factor scores: Quality 55/100, Value 78/100, Momentum 80/100. The timing signal is "Neutral". This is quantitative analysis only — not investment advice.

What is the stock rating for LION?

Lionsgate Studios Corp. (LION) has a "Hold" rating and 3-star score. The composite score of 57.1 ranks it #1010 among 7,333 U.S. stocks. Ratings are updated weekly using academically-proven factor models.

What sector is LION in?

Lionsgate Studios Corp. operates in the Services sector (Entertainment industry) with a market cap of $2.19 billion. It is classified as a mid-cap stock.

Does LION pay a dividend?

LION does not currently pay a regular dividend. The company may be reinvesting profits for growth.

What is LION's P/E ratio?

LION has a trailing P/E ratio of 65.30x. The Services sector average is 23.7x. This above-average P/E reflects growth expectations or premium valuation.

How profitable is LION?

LION's quality factor score is 55/100. Gross margin: 100.0%. ROE: 0.0% vs sector average 5.7%. High margins suggest pricing power and competitive moats.

How is LION valued compared to peers?

LION's value factor score is 78/100 (higher = cheaper). Key multiples: P/E 65.3x, EV/EBITDA 12.4x. The stock appears attractively valued versus peers.

What is LION's debt level?

Debt data is not available for LION.

LION has a beta of 0.82, meaning it tracks the market. Stability score: 57/100.

Does LION have high short interest?

LION's short interest factor score is 27/100 (higher = less short selling). Elevated short interest may indicate bearish sentiment or short squeeze potential.

LION Stock Analysis — Lionsgate Studios Corp. Price Target & Forecast 2026

IMPORTANT DISCLAIMER: Blank Capital Research ("BCR") is a technology platform, not a registered investment advisor or broker-dealer. The algorithmically generated signals, scores, and rankings provided on this site ("God Mode" Signals) are for informational and research purposes only and do not constitute financial advice, investment recommendations, or an offer to sell or solicit an offer to buy any securities.

HYPOTHETICAL PERFORMANCE RESULTS: The "timing scores" and "regime signals" displayed are based on quantitative models. Hypothetical or simulated performance results have certain inherent limitations. Unlike an actual performance record, simulated results do not represent actual trading. Also, since the trades have not actually been executed, the results may have under-or-over compensated for the impact, if any, of certain market factors, such as lack of liquidity.

RISK OF LOSS: Trading in financial markets involves a high degree of risk and may result in the loss of your entire investment. Data provided by third-party sources (Intrinio, Snowflake) is believed to be reliable but is not guaranteed for accuracy or completeness. Past performance is not indicative of future results.

LION Stock Analysis — Lionsgate Studios Corp. Price Target & Forecast 2026 | Blank Capital Research

Sector

Services

Industry

Entertainment

Market Cap

$2.2B

Leadership

Jon Feltheimer

Business Summary

Deep Value

Lions Gate Entertainment Corp (Lionsgate) is a provider of entertainment services. The company offers services such as motion picture production and distribution, television programming and series, home entertainment, international distribution and sales, games, music, and location-based entertainment. It also offers its services through the Starz network, OTT platforms, US multichannel video programming distributors. It leases offices used by its network motion picture, television production, and media networks in India, the US, the UK, and Luxembourg. Lionsgate is headquartered in Santa Monica, California, the US.

Operations

Headcount

—

Fundamental Spot Check

Context: 2025

Valuation

Market Cap

$2.2B

P/E Ratio

65.3xLagging

P/B Ratio

P/S Ratio

1.01xOutperforming

EV/EBITDA

12.4xLagging

Dividend Yield

0.00%

Efficiency & Risk

Gross Margin

100.0%Outperforming

Operating Margin

0.1%Lagging

ROE

0.0%

Rev Growth (YoY)

-12.1%

Debt/Equity

Beta

0.82

Red = Sector Laggard

Black = Market Average

Revenue Breakdown

Strategic Timing Audit

CAUTION

2/6

Mixed Alignment [2 BULL / 1 BEAR]

Quantitative Factor Convergence Analysis Verified

Momentum

80th pctl

Intelligence Feed

BenzingaMar 2 Negative

Why Cano Health Shares Are Trading Lower By Around 23%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Gainers Exela Technologies, Inc. (NASDAQ: XELA) shares surged 45% to $0.0701 after the company announced $51 million of new funding, amendment increases existing securitization facility to $185 million and other related transactions. BioRestorative Therapies, Inc. (NASDAQ: BRTX) shares jumped 34.7% to $3.76 after the company announced the United States Patent and Trademark Office has issued a notice of allowance for a patent application related to the Company's metabolic ThermoStem program. Diversified Healthcare Trust (NASDAQ: DHC) surged 30% to $1.21 after the company posted a profit for the fourth quarter. Desktop Metal, Inc. (NYSE: DM) gained 23% to $1.8550 after the company reported better-than-expected Q4 sales results and issued guidance. OncoSec Medical Incorporated (NASDAQ: ONCS) gained 22.7% to $2.52. OncoSec Medical shares jumped around 89% on Wednesday after the company requested the withdrawal of its registration statement, saying it has opted not to pursue the offering at this time. Frontdoor, Inc. (NASDAQ: FTDR) shares climbed 16.8% to $32.67 after the company posted Q4 results. China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) gained 16% to $4.55. FOXO Technologies Inc. (NASDAQ: FOXO) gained 16% to $0.6128. Advantage Solutions Inc. (NASDAQ: ADV) gained 15.9% to $2.5850 following strong quarterly sales. Macy's, Inc. (NYSE: M) gained 13.3% to $23.15 after the company reported better-than-expected Q4 adjusted EPS and sales results and issued guidance. Okta, Inc. (NASDAQ: OKTA) shares rose 13.2% to $80.84 after the company reported better-than-expected Q4 results and issued strong guidance. Stagwell Inc. (NASDAQ: STGW) gained 12% to $7.61 following upbeat quarterly results. Salesforce, Inc. (NYSE: CRM) rose 11.5% to $186.64 after the company reported better-than-expected Q4 results ...

BenzingaMar 2 Negative

Why Salesforce Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket

Gainers MMTec, Inc. (NASDAQ: MTC) rose 76% to $2.78 in pre-market trading after jumping 37% on Wednesday. On February 22, MMTec raised $32 million by issuing an unsecured senior convertible promissory note worth $40 million to a non-U.S. investor under a securities purchase deal. Blue Star Foods Corp. (NASDAQ: BSFC) rose 71.7% to $0.28 in pre-market trading. Blue Star Foods recently priced a $1.8 million underwritten public offering of common stock. Lucira Health, Inc. (NASDAQ: LHDX) rose 15.2% to $0.91 in pre-market trading after dropping 15% on Wednesday. Lucira Health recently announced FDA authorization for its at-home combination COVID-19 & flu test. Salesforce, Inc. (NYSE: CRM) rose 14.7% to $192.00 in pre-market trading after the company reported better-than-expected Q4 results and issued strong guidance. Okta, Inc. (NASDAQ: OKTA) shares rose 14.1% to $81.51 in pre-market trading after the company reported better-than-expected Q4 results and issued strong guidance. HPX Corp. (NYSE: HPX) rose 13.8% to $30.80 in pre-market trading after shareholders approved the proposed business combination with Emergencia ...

BenzingaMar 1 Neutral

Why Reata Pharmaceuticals Shares Are Trading Higher By 140%; Here Are 20 Stocks Moving Premarket

Gainers Reata Pharmaceuticals Inc (NASDAQ: RETA) rose 140.8% to $75.06 in pre-market trading after the company reported the FDA approval of SKYCLARYS for patients with Friedreich's Ataxia. OncoSec Medical Incorporated (NASDAQ: ONCS) rose 75.9% to $1.90 in pre-market trading after the company requests withdrawal of registration statement, The company said it has opted not to pursue offering thereby at this time. Lionheart III Corp (NASDAQ: LION) shares rose 56.2% to $22.80 in pre-market trading after jumping around 98% on Tuesday. China Pharma Holdings Inc (NASDAQ: CPHI) rose 20.8% to $0.081 in pre-market trading. China Pharma recently announced a 1-for-10 reverse stock split. Helbiz Inc (NASDAQ: HLBZ) rose 19.1% to $0.17 in pre-market trading after gaining over 21% on Tuesday. Sarepta Therapeutics Inc (NASDAQ: SRPT) rose 17% to $142.90 in pre-market trading after the company reported better-than-expected Q4 results. Landos Biopharma Inc (NASDAQ: LABP) shares rose 14.9% to $0.43 in pre-market trading. Landos Biopharma announced transfer ...

BenzingaFeb 1 Neutral

Why WestRock Company Are Trading Lower By 13%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Gainers Versus Systems Inc. (NASDAQ: VS) surged 270% to $2.26 after the company announced it will partner with Resolve to bring generative AI and gamification to customer payments and credit management. EBET, Inc. (NASDAQ: EBET) gained 108% to $1.97 Motorsport Games Inc. (NASDAQ: MSGM) shares jumped 92.3% to $41.15. Motorsport Games agreed to raise $3.9 million at par via private placement of shares for developing multiple games, working capital and general corporate purposes. Bright Green Corporation (NASDAQ: BGXX) gained 91.3% to $0.9993. Bright Green announced plans to raise $500 million under EB-5 Capital Program. Recruiter.com Group, Inc. (NASDAQ: RCRT) rose 80.4% to $0.8520. Recruiter.com Group reported the launch of a comprehensive content series that explores the powerful impact of the artificial intelligence technology, ChatGPT, on talent acquisition and recruiting. SharpLink Gaming Ltd. (NASDAQ: SBET) gained 50% to $0.81 Iveda Solutions, Inc. (NASDAQ: IVDA) jumped 47.2% to $1.39 Mobile Global Esports Inc. (NASDAQ: MGAM) gained 36.1% to $3.51 after jumping 158% on Tuesday. Mobile Global Esports said Nicholas (Nick) Venezia has joined MOGO as Chief Data Officer. Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) shares climbed 36% to $2.27 after gaining around 10% on Tuesday. Impac Mortgage Holdings, Inc. (NYSE: IMH) jumped 25% to $0.3350. Chembio Diagnostics, Inc. (NASDAQ: CEMI) rose 23.3% to $0.4401. Biosynex and Chembio Diagnostics reported a definitive acquisition agreement. Rapid7, Inc. (NASDAQ: RPD) gained 23.2% to $49.13. Rapid7 is working with Goldman Sachs Group to explore a potential sale, Reuters reported. ERYTECH Pharma S.A. (NASDAQ: ERYP) jumped 22.2% to $1.10. Engine Gaming and Media, Inc. (NASDAQ: GAME) gained 22.2% to $1.4673. Pintec Technology Holdings Limited (NASDAQ: PT) jumped ...

BenzingaFeb 1 Positive

Why TransCode Therapeutics Shares Are Trading Higher By 42%; Here Are 20 Stocks Moving Premarket

Gainers Motorsport Games Inc. (NASDAQ: MSGM) shares rose 121% to $47.48 in pre-market trading after jumping over 710% on Tuesday. The company announced a debt-for-equity exchange with Motorsport Network. Also, Investor Mike Zoi reported purchase of 338,983 shares of Motorsport Games at an average price of $2.95 per share in Form 4 Filing. Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) shares rose 67% to $2.77 in pre-market trading after gaining around 10% on Tuesday. TransCode Therapeutics, Inc. (NASDAQ: RNAZ) rose 42.5% to $1.07 in pre-market trading after the company reported preclinical results with immunotherapy candidate TTX-RIGA in melanoma. Wearable Devices Ltd. (NASDAQ: WLDS) shares rose 39.2% to $1.10 in pre-market trading after gaining around 20% on Tuesday. Genetic Technologies Limited (NASDAQ: GENE) rose 35.2% to $1.23 in pre-market trading. Genetic Technologies is forming strategic alliance with Qiagen, Reuters reported. Lionheart III Corp (NASDAQ: LION) rose 30.2% to $13.50 in pre-market trading after dropping over 10% on Tuesday. Marin Software Incorporated (NASDAQ: MRIN) rose 25.6% to $1.52 in pre-market trading after the company disclosed a new integration with Yahoo to enable enhanced campaign buying and optimization for advertisers. Chembio Diagnostics, Inc. (NASDAQ:

Earnings Call Transcripts

Unlock Valuation Tools

Get full access to institutional-quality research tools with Blank Capital Pro.

Upgrade to Pro

Starting at $19.99/mo

Financial Intelligence Ledger

Verified SEC Filings Aggregate • LION

Export

Metric Entity	10Y Historical Trend	2021	2018	2017	2016	2015
Revenue		—	$187M30.7%	$270M0.0%	$270M18.1%	$229M
Cost of Revenue		—	$38M72.1%	$135M4.5%	$141M10.5%	$128M
Gross Profit		—	$150M10.6%	$135M5.0%	$129M27.8%	$101M
R&D Expense	-	—	—	—	—	—
Operating Expenses		—	$11M	$296K102.4%	-$12M53.8%	-$27M
Operating Income		-$345K100.2%	$139M2.9%	$135M4.5%	$141M10.5%	$128M
Interest Expense		—	$32M40.3%	$23M11.2%	$20M29.4%	$16M
Tax Provision		—	$14M9.8%	$15M31.1%	$22M0.7%	$22M
EBITDA		-$345K99.1%	-$40M8.1%	-$37M23.5%	-$30M144.7%	$68M
Net Income		-$343K100.8%	$44M10.1%	$40M2.7%	$39M0.9%	$39M
EPS (Diluted)		-	$1.617.3%	$1.501.3%	$1.5214.1%	$1.77

SEC EDGAR Repository

Direct unfiltered access to 10-K, 10-Q and 8-K filings for LION.

Open Regulatory Dossier

Data Integrity Notice

Figures adjusted for stock splits and restatements where applicable.

TTM (Trailing Twelve Months) data updates within 48 hours of quarterly filings.

Execution Benchmarks Audit

Revenue Growth

YOY expansion rate

-241% SCTR

-12.1%

Sector Avg: 8.6%

Gross Margin

Core pricing power

+55% SCTR

100.0%

Sector Avg: 64.6%

Operating Margin

Operating efficiency

-99% SCTR

0.1%

Sector Avg: 4.5%

Return on Equity

Equity efficiency

-100% SCTR

0.0%

Sector Avg: 5.7%

Dividend Yield

Direct cash return

-NaN% SCTR

0.0%

Sector Avg: 0.0%

Financial History

Forensic Accounting Audit

Verified

Asset Efficiency

Improving capital utilization rates confirmed

Algorithmic red flag detection based on regulatory SEC filings.

Unlock Financial Statements

Get full access to institutional-quality research tools with Blank Capital Pro.

Upgrade to Pro

Starting at $19.99/mo

Shareholder Returns

Capital Allocation audit

Smart Money Conviction

Neutral

Synthesized from recent 13F filings, Form 4 insider transactions, and outstanding short interest metrics.

Governance Audit

Weak Index

WeakModerateStrong

Lower quality and stability scores may indicate governance concerns. Verified against factor-based integrity benchmarks.

Executive Operations

CEO: Jon Feltheimer

Insider alignment Audit

No recent insider transactions available for LION

Major Institutional Blocks

Top 5 Holders

Institutional cap table data requires verified 13F filing feeds.

Access SEC 13F Dossier →

Form 4 Filings

Recent Activity

Insider transaction data currently awaiting regulatory verification.

Access SEC Form 4 Dossier →

Regulatory Disclosure Vault

Proxy Statement (DEF 14A)

Exec Comp, Board Nominees, Proposals

Annual Report (10-K)

MD&A, Risk Factors, Strategy

Institutional Holders (13F)

Loading institutional data...

Insider Liquidity

Short Interest Trend

0.0% FLOAT SHORT

Float Short

0.00%

Days to Cover

2.92

Total Short

7.42M

Cycle \u0394

+4.8%

Settlement History (4 Periods)

Jun 25Aug 25

Audit: Regulatory FINRA Feed \u00B7 2025-08-15Access Short Volume Feed →

Unlock Governance & Ownership

Get full access to institutional-quality research tools with Blank Capital Pro.

Upgrade to Pro

Starting at $19.99/mo

Unlock Factor Analysis

Get full access to institutional-quality research tools with Blank Capital Pro.

Upgrade to Pro

Starting at $19.99/mo

Unlock Investment Thesis

Get full access to institutional-quality research tools with Blank Capital Pro.

Upgrade to Pro

Starting at $19.99/mo

Institutional Peer Matrix

Top Services Universe

Factor Alpha Dispersion: Value vs. Quality

Quadrant I: High Quality / Undervalued

Quadrant III: Low Quality / Expensive

X-AXIS: EV/EBITDA (LOWER = CHEAPER) | Y-AXIS: ROE (HIGHER = ELITE) | RED CIRCLE = LION ANALYSIS TARGET

Stock	Rating	Score▼	Quality	Value	Momentum	P/E	EV/EBITDA	ROE	ROA	Gross Mgn	Op Mgn	Net Mgn	Rev Growth	Div Yield	D/E	Mkt Cap	AUDIT
$YALA Yalla Group Ltd		75	89	99	80	-	-	-	-	-	-	-	-	-	-	$0	VS
$GRVY GRAVITY Co., Ltd.		75	82	96	71	-	-	-	-	-	-	-	-	-	-	$0	VS
$ISSC INNOVATIVE SOLUTIONS & SUPPORT INC		73	81	88	94	25.0x	14.1x	17.1%	10.3%	35.5%	14.6%	10.1%	105.2%	0.0%	41.0x	$244M	VS
$AER AerCap Holdings N.V.		72	60	87	84	-	-	-	-	-	-	-	-	-	-	$0	VS
$HCSG HEALTHCARE SERVICES GROUP INC		72	74	88	88	7.1x	6.1x	28.9%	20.8%	20.8%	9.9%	9.3%	8.5%	0.0%	1.0x	$1.2B	VS
$LQDT LIQUIDITY SERVICES INC		72	90	88	68	24.9x	14.3x	14.1%	8.3%	45.7%	8.5%	6.2%	28.1%	0.0%	0.0x	$736M	VS
$TRTNpA Triton International Ltd		71	70	89	70	-	1.7x	0.0%	-	97.4%	58.0%	37.4%	-	8.8%	264.0x	$2.5B	VS
$EDU New Oriental Education & Technology Group Inc.		71	83	52	77	-	-	-	-	-	-	-	-	-	-	$0	VS
$NTES NetEase, Inc.		71	88	93	68	-	-	-	-	-	-	-	-	-	-	$0	VS
$UTI UNIVERSAL TECHNICAL INSTITUTE INC		70	86	86	72	43.2x	16.0x	15.3%	5.8%	100.0%	6.9%	5.2%	15.1%	0.0%	24.0x	$1.8B	VS
$LION Lionsgate Studios Corp.		57	55	78	80	65.3x	12.4x	0.0%	-4.9%	100.0%	0.1%	-12.3%	-12.1%	0.0%	-	$2.2B
SECTOR BENCH	-	-	-	-	-	23.7x	11.7x	5.7%	2.4%	64.6%	4.5%	2.8%	8.6%	0.0%	0.3x	-	REF

Access Full Services Intelligence Archive →

Lateral Comparison Mesh

$LION / $YALA AUDIT $LION / $GRVY AUDIT $LION / $ISSC AUDIT $LION / $AER AUDIT $LION / $HCSG AUDIT

Market Intelligence FAQ

Lionsgate Studios Corp. (LION) receives a "Hold" rating with a composite score of 57.1/100. It ranks #1010 out of 7,333 stocks in our coverage universe and carries a 3-star rating. Ratings are driven by a 6-factor quantitative model measuring quality, value, momentum, investment, stability, and short interest.

Full Research Publication

Equity Research Analysis: Lionsgate Studios Corp. (LION)

FEBRUARY 2026|Blank Capital Research Unit|Spot: $8.21

Price$8.21

Composite Score57.1/100

RatingHOLD (3★)

Rank#1010 OF 7,333

Market Cap$2.2B

Comments

Institutional Audit

Feb 25, 2026

Lionsgate Studios Corp.

57.1

Sector Decomposition auditServices [N=802]

Factor	Global	Sector	Tilt
PROFITABILITY	55	67	-12DRAG
MOMENTUM	80	89	-9DRAG
VALUATION	78	89	-11DRAG
INVESTMENT	31	36	-5NEUTRAL
STABILITY	57	62	-5NEUTRAL
SHORT INT	27	12	+15ALPHA

Global = full universe. Sector = relative to industry peers. Positive tilt indicates idiosyncratic strength.

Executive Summary

Our model assigns Lionsgate Studios Corp. a Hold rating, with a composite score of 57.1/100 and 3 out of 5 stars. Ranked #1010 of 7,333 stocks, LION presents a mixed quantitative picture — neither compelling enough to initiate new positions nor weak enough to warrant selling. Investors already holding may consider maintaining their position while monitoring for changes in the factor profile.

Business Quality

With a quality score of 55/100, LION shows adequate but unremarkable business quality. The company reports a return on equity of 0.0% (sector avg: 5.7%), gross margins of 100.0% (sector avg: 64.6%), net margins of -12.3% (sector avg: 2.8%). This suggests the company generates acceptable returns but may lack the competitive positioning or operational efficiency to stand out from peers.

Intrinsic Valuation

LION carries a solid value score of 78/100, pointing to an attractively priced stock relative to peers. Key valuation metrics include a P/E ratio of 65.30x, an EV/EBITDA of 12.37x. This score suggests reasonable compensation for the risks involved, with potential upside if the market recognizes the stock's underlying worth.

Capital Reinvestment

Lionsgate Studios Corp.'s investment score of 31/100 suggests limited reinvestment activity. Key growth metrics include revenue growth of -12.1% vs. a sector average of 8.6% and a return on assets of -4.9% (sector: 2.4%). While this can be positive for mature, cash-generative businesses returning capital to shareholders, it may also signal a lack of growth opportunities or management conservatism.

Market Momentum

LION shows strong momentum characteristics with a score of 80/100. The stock has been trending above key moving averages, indicating solid demand from institutional buyers. Revenue growth stands at -12.1% year-over-year, while a beta of 0.82 reflects its sensitivity to broader market moves. This level of momentum typically signals sustained investor confidence and favorable near-term price action.

Balance Sheet Health

With a stability score of 57/100, LION exhibits average financial resilience. Key stability metrics include a beta of 0.82. While the balance sheet is not a major concern, the stock is subject to typical market volatility and may experience sharper drawdowns during risk-off episodes.

Institutional Risk Profile

Lionsgate Studios Corp.'s short interest score of 27/100 reveals significant bearish positioning, suggesting institutional investors are actively betting against the stock. At $2.2B (mid-cap), LION carries meaningful risk and is best suited for investors with high risk tolerance who have thoroughly evaluated the bear thesis.

Sector Benchmark Analysis

Lionsgate Studios Corp. is a mid-cap company in the Services sector, ranked #0 of 50 in its sector (100th percentile) and #1010 of 7,333 overall (86th percentile). Key comparisons include ROE of 0.0% trailing the 5.7% sector median and operating margins of 0.1% below the 4.5% sector average. This top-quartile standing reflects exceptional competitive strength relative to Services peers.

Comparative Research Mesh

LION VS S&P 500 (SPY)TOP SERVICES PEERS

Strategic Alternatives

While LION currently exhibits a HOLD profile, superior opportunities exist within the SERVICES sector. Our model identifies several "Strong Buy" candidates with higher quality scores and more attractive valuations among direct industry competitors.

View Top Services Alpha →

LION

Lionsgate Studios Corp.

Business Summary

Operations

Fundamental Spot Check

Valuation

Efficiency & Risk

Intelligence Feed

Why Cano Health Shares Are Trading Lower By Around 23%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Why Salesforce Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket

Why Reata Pharmaceuticals Shares Are Trading Higher By 140%; Here Are 20 Stocks Moving Premarket

Why WestRock Company Are Trading Lower By 13%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Why TransCode Therapeutics Shares Are Trading Higher By 42%; Here Are 20 Stocks Moving Premarket

Unlock Valuation Tools

Unlock Financial Statements

Unlock Governance & Ownership

Unlock Factor Analysis

Unlock Investment Thesis

Factor Alpha Dispersion: Value vs. Quality

Lateral Comparison Mesh

Comments

Location

Unlock Performance & Technicals

SEC Risk Factors

Economic Moat Audit

Economic Value Creation

Margin Superiority

Reinvestment Efficiency

Growth Durability

Financial Resilience

Uncertainty Audit

BEAR THESIS

01Executive Summary

02Strategy & Outlook

Risk / Reward Variance

Research Verdict

Related Stocks

Executive Summary

Business Quality

Intrinsic Valuation

Capital Reinvestment

Market Momentum

Balance Sheet Health

Institutional Risk Profile

Sector Benchmark Analysis

Comparative Research Mesh

Strategic Alternatives

Factor Dispersion Audit

Sector Variance Findings

Market Intel

Intelligence Feed

Why Cano Health Shares Are Trading Lower By Around 23%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Why Salesforce Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket

Why Reata Pharmaceuticals Shares Are Trading Higher By 140%; Here Are 20 Stocks Moving Premarket

Why WestRock Company Are Trading Lower By 13%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Why TransCode Therapeutics Shares Are Trading Higher By 42%; Here Are 20 Stocks Moving Premarket